Positively Aware Vemildy HBV

Vemlidy

tenofovir alafenamide, or TAF (25 mg)

 
Nucleoside "Nuke"

Standard Dose

One 25 mg tablet once per day, with food. There is no dose adjustment for people with creatinine clearance (CrCl) greater than 15 mL/min or for people with end stage kidney disease who are on hemodialysis. On days of dialysis, Vemlidy should be taken upon completion of dialysis. Vemlidy is safe for people with mild liver damage (Child-Pugh A), but it should not be used in patients with decompensated cirrhosis (Child-Pugh B or C). Take missed dose as soon as possible, unless it is closer to the time of your next dose. Do not double up on your next dose.

Manufacturer

Gilead Sciences

AWP

$1,343 / month

Potential Side Effects and Toxicity

Potential Drug Interactions

More Information